跳至主要内容
临床试验/NL-OMON43132
NL-OMON43132已完成不适用

The effect of intravenous lactate administration on brain lactate concentrations and pH during euglycemia and hypoglycemia in patients with type 1 diabetes with and without impaired awareness of hypoglycemia - The effect of intravenous lactate on brain lactate during hypoglycemia

Radboud Universitair Medisch Centrum0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Diabetes duration * 1 year
  • - Age: 18-50 years
  • - Body-Mass Index: 18-30 kg/m2
  • - HbA1c: 42-75 mmol/mol (6-9%)
  • - Outcome Clarke questionnaire: 0-1 or ><=3
  • - Blood pressure: <160/90 mmHg

排除标准

  • - Inability to provide informed consent
  • - Use of medication other than insulin, oral contraceptives or stable thyroxine supplementation therapy
  • - Presence of any other medical condition that might interfere with the study protocol, such as brain injuries, epilepsy, a major cardiovascular disease event, known liver disease, anxiety disorders or a history of panic attacks.
  • - Microvascular complications of T1DM except background retinopathy
  • - MR(I) contraindications, such as pregnancy, severe claustrophobia, metal parts in body

研究者

相似试验